Multiple Sclerosis: Is Clinical Efficacy Sidetracked by Health Economics?

Journal of Economics Theory
doi 10.3923/jeth.2012.91.98
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Medwell Publications

Related search

Integrative Group-Based Cognitive Rehabilitation Efficacy in Multiple Sclerosis: A Randomized Clinical Trial

Disability and Rehabilitation
Rehabilitation
2016English

Clinical Features of Childhood Multiple Sclerosis

AAP Grand Rounds
2003English

The Clinical Neuropsychiatry of Multiple Sclerosis

British Journal of Psychiatry
MedicinePsychiatryMental Health
2000English

Alternative Statistical Methods for Estimating Efficacy of Interferon Beta-1b for Multiple Sclerosis Clinical Trials

BMC Medical Research Methodology
EpidemiologyHealth Informatics
2011English

Efficacy of Natalizumab and Fingolimod in Relapsing Remitting Multiple Sclerosis in Real World Clinical Setting

Journal of Neurology & Neurophysiology
2015English

Bone Health in Patients With Multiple Sclerosis

Journal of Osteoporosis
EndocrinologyMetabolismDiabetes
2011English

The Present Efficacy of Multiple Sclerosis Therapeutics: Is the New 66% Just the Old 33%?

Neurology
Neurology
2009English

Retinal Oximetry Is Affected in Multiple Sclerosis

Acta Ophthalmologica
MedicineOphthalmology
2018English

Linking Genotype to Clinical Phenotype in Multiple Sclerosis

JAMA Neurology
Neurology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy